LRRK2 and Alzheimer disease: Overall, these observations support a key contribution of neuroinflammation in promoting AD pathogenesis and, importantly, suggest that LRRK2, which is a positive mediator of neuroinflammation, could mediate and contribute to AD pathogenesis.